STEVEN MICHAEL SNODGRASS M.D.
Prescription History 1982805487
Pediatrics - Pediatric Pulmonology in Greenville, SC

NPI Status: Active since May 30, 2007

Contact Information

200 PATEWOOD DR
SUITE A300
GREENVILLE, SC
ZIP 29615
Phone: (864) 454-5530
Fax: (864) 241-9246

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for STEVEN MICHAEL SNODGRASS M.D., an active Pediatric Pulmonology specialist practicing in Greenville, SC. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Trikafta, which accounts for 12 claims alone.

Medication Index

No matching medications currently found on file.

Trikafta

Generic Formulation: Elexacaftor/Tezacaftor/IvacaftSpecialty: Pediatric Medicine
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 336
SC State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills62.7
Peer Average Days Supply1,771
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 79.3% less volume than the regional standard for practitioners inside SC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $338,406.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$28,200.52

State Avg Cost Per Claim

$27,217.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product has 2 different tablets. One tablet contains 3 medications (it is a multi-drug): elexacaftor, tezacaftor, and ivacaftor. The other tablet contains only ivacaftor. This product is used to treat cystic fibrosis in certain people (those with an abnormal CFTR gene). It may help to improve breathing, reduce the risk of lung infections, and improve weight gain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like STEVEN MICHAEL SNODGRASS M.D. provides transparency into local medical care patterns within Greenville, SC.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pediatric Pulmonology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.